arBtrage CAPITALIZING MARKETS checking… Sign in

Neurogene Inc.

NGNE Health Care Biotechnology: Pharmaceutical Preparations
$26.49
▼ -3.6% Today
as of Jun 7, 07:22 ET
Last 30 days -3.50% Apr 28 → Jun 05
$25.57 $27.46 $29.35 $31.25 $33.14 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$27.48
High
$27.50
Low
$26.02
Volume
$66,263
Avg Vol
$178,860
Mkt Cap
$435M
P/E (TTM)
Beta
52w High
$37.27
52w Low
$14.65
Div Yield
Shares Out
$16M

Overview

52-week range
$15
$37
52% of range
Avg surprise (last 2)
-2.9%
Avg reaction (last 2)
+0.2%
50% positive
Latest IV / EM
213%
EM ±29.4% · $25 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-32.67$-24.75$-16.83$-8.91$-0.99 Actual $-26.68Actual $-32.67Actual $-1.00Actual $-1.09Actual $-1.19Actual $-1.08Est $-1.05Actual $-1.05Actual $-0.99Actual $-1.39Est $-1.35 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-31M$-23M$-15M$-7M$971,250 Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue May 12, 2026Mar/2026 $-1.39 $-1.35 -3.0% -28.7% +2.1% earnings
Tue Sep 30, 2025Sep 2025 $-0.99 financials
Mon Jun 30, 2025Jun 2025 $-1.05 financials
Fri May 9, 2025Mar/2025 $-1.08 $-1.05 -2.9% -1.8% earnings
Mon Sep 30, 2024Sep 2024 $-1.19 financials
Sun Jun 30, 2024Jun 2024 $-1.09 financials
Sun Mar 31, 2024Mar 2024 $-1.00 financials
Sat Sep 30, 2023Sep 2023 $-32.67 financials
Fri Jun 30, 2023Jun 2023 $-26.68 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$0$0$0$925,000
Cost of revenue
Gross profit
Operating income$-33M$-24M$-26M$-26M$-22M$-20M
Net income$-31M$-21M$-22M$-23M$-20M$-18M
EPS (diluted)$-1.39$-0.99$-1.05$-1.08$-1.19$-1.09

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$124M$104M$71M$59M$71M$137M$67M$111M
Inventory
Total current assets$247M$272M$271M$279M$296M$316M$144M$159M
Total assets$263M$289M$288M$297M$315M$336M$164M$180M
Long-term debt
Total liabilities$25M$24M$22M$24M$24M$25M$27M$25M
Total equity$238M$265M$266M$273M$292M$310M$137M$155M

Implied volatility — last 90 days

207%210%212%215%217% Jun 07 — IV 213% · EM ±29.4%

Sector peers